Systemic Recovery Support for Soft Tissue, Mobility, and Tissue Remodeling

TB-500 is a thymosin beta-4–derived peptide fragment often used in recovery-focused protocols for its role in cell migration, tissue remodeling, and vascular support. It’s typically chosen when the goal is whole-body soft tissue recovery—especially when multiple areas are strained or training volume is high.

Key Benefits (Research Focus)

• Supports systemic soft tissue repair (muscle, fascia, connective tissue)
• Promotes tissue remodeling and recovery capacity
• Supports angiogenesis/blood flow signaling, which is important for healing
• Often used to support mobility, tightness, and overuse recovery
• Non-hormonal and non-suppressive

How It Works (High Level)

TB-500 is associated with pathways involved in:

• Actin/cytoskeleton dynamics (important for cell movement into injured tissue)
• Repair signaling and tissue remodeling
• Vascular support that helps deliver oxygen and nutrients to recovering tissue

Typical Dosage & Injection Use (Informational)

Commonly referenced injectable protocols:

• Loading phase: 2–5 mg, 2× weekly for 2–4 weeks
• Maintenance phase: 2–5 mg, 1× weekly for 2–6 weeks as needed
• Administration: typically subcutaneous injection

(Protocols vary by goal, injury severity, and clinician preference.)

Safety & Best Practices

• Use only with guidance of a licensed medical professional
• Follow strict sterile technique
• Possible mild effects: injection-site irritation, temporary fatigue/lightheadedness (uncommon)
• Avoid use during pregnancy/nursing, under 18, or with serious medical conditions unless cleared by a clinician

Important: TB-500 is not FDA-approved for human therapeutic use and is often sold as research-use-only. It is also prohibited by WADA for tested athletes.

How to Pair TB-500 with BPC-157

If you’re combining peptides, many protocols pair:

• TB-500 for systemic recovery and tissue remodeling support
• BPC-157 for localized tendon/ligament/joint support (and gut-support goals)

Simple Pairing Approach (Informational)

• Run TB-500 as your base (loading → maintenance as above)
• Add BPC-157 alongside it:
  • 250–500 mcg daily (or split AM/PM)
  • Often injected subcutaneously near the affected area when targeting a specific tendon/ligament/joint
  • Typical duration: 2–6 weeks

Why This Pair Works

• TB-500 helps create a broad repair environment
• BPC-157 adds targeted connective tissue support, which is helpful for stubborn, slow-healing areas

Use Responsibly

Only stack under medical supervision—stacking increases variables (dose, timing, response), and injection safety and sourcing quality matter most.